Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 1
2014 3
2015 29
2016 211
2017 206
2018 232
2019 160
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

698 results
Results by year
Filters applied: . Clear all
Page 1
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderk├Âtter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C; German Dermatologic Cooperative Oncology Group (DeCOG). Leiter U, et al. Lancet Oncol. 2016 Jun;17(6):757-767. doi: 10.1016/S1470-2045(16)00141-8. Epub 2016 May 5. Lancet Oncol. 2016. PMID: 27161539 Clinical Trial.
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
El Hage Chehade H, Headon H, El Tokhy O, Heeney J, Kasem A, Mokbel K. El Hage Chehade H, et al. Am J Surg. 2016 Nov;212(5):969-981. doi: 10.1016/j.amjsurg.2016.07.018. Epub 2016 Aug 16. Am J Surg. 2016. PMID: 27671032 Review.
Time to reconsider the role of sentinel lymph node biopsy in melanoma.
Bigby M, Zagarella S, Sladden M, Popescu CM. Bigby M, et al. J Am Acad Dermatol. 2019 Apr;80(4):1168-1171. doi: 10.1016/j.jaad.2018.11.026. Epub 2018 Nov 22. J Am Acad Dermatol. 2019. PMID: 30471314
698 results
Jump to page
Feedback